Beam Therapeutics, Inc.(BEAM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BEAM Beam Therapeutics, Inc.

休市中 09-19 16:00:00 EDT

24.32

-0.78

-3.11%

盘后24.63

+0.31+1.27%

19:58 EDT

最高25.69	最低24.11	成交量427.10万
今开25.39	昨收25.10	日振幅6.30%
总市值24.60亿	流通市值21.87亿	总股本1.01亿
成交额1.05亿	换手率4.75%	流通股本8,994万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BEAM","market":"US","secType":"STK","nameCN":"Beam Therapeutics, Inc.","latestPrice":24.32,"timestamp":1758312000000,"preClose":25.1,"halted":0,"volume":4271034,"hourTrading":{"tag":"盘后","latestPrice":24.63,"preClose":24.32,"latestTime":"19:58 EDT","volume":363443,"amount":8839274.5081,"timestamp":1758326309384},"delay":0,"floatShares":89942800,"shares":101162026,"eps":-4.620702,"marketStatus":"休市中","change":-0.78,"latestTime":"09-19 16:00:00 EDT","open":25.39,"high":25.6913,"low":24.11,"amount":105413014.30300799,"amplitude":0.063,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.620702,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1758528000000},"marketStatusCode":7,"adr":0,"listingDate":1580965200000,"exchange":"NASDAQ","adjPreClose":25.1,"preHourTrading":{"tag":"盘前","latestPrice":25.38,"preClose":25.1,"latestTime":"09:29 EDT","volume":8233,"amount":207430.122146,"timestamp":1758288599999},"postHourTrading":{"tag":"盘后","latestPrice":24.63,"preClose":24.32,"latestTime":"19:58 EDT","volume":363443,"amount":8839274.5081,"timestamp":1758326309384},"volumeRatio":1.4099103197405536,"impliedVol":0.8446,"impliedVolPercentile":0.9},"requestUrl":"/m/hq/s/BEAM","defaultTab":"news","newsList":[{"id":"1130632456","title":"异动解读 | Beam Therapeutics股价盘中大跌5.08%，Q2财报显示亏损扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=1130632456","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130632456?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:56","pubTimestamp":1754488617,"startTime":"0","endTime":"0","summary":"周三盘中，基因编辑技术公司Beam Therapeutics, Inc.股价大幅下跌5.08%，引发市场关注。这一显著跌幅与公司最新发布的第二季度财务报告密切相关。根据Beam Therapeutics发布的2025财年第二季度财报，公司业绩表现不佳。报告显示，2025年前六个月公司累计收入为1593.60万美元，较去年同期的1918.20万美元下降16.92%。分析人士指出，Beam Therapeutics的收入下滑和亏损扩大可能是导致股价大跌的主要原因。作为一家专注于开发精密基因药物的生物科技公司，投资者对其财务状况和研发进展高度敏感。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BEAM"],"gpt_icon":0},{"id":"1139618416","title":"异动解读 | Beam Therapeutics盘中大跌5.08%，Q2财报显示业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=1139618416","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139618416?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:56","pubTimestamp":1754488612,"startTime":"0","endTime":"0","summary":"生物科技公司Beam Therapeutics今日盘中股价大跌5.08%，引发市场关注。这一股价下跌主要受到公司最新发布的第二季度财报影响，财报显示公司业绩出现明显下滑。根据Beam Therapeutics发布的财报，2025财年前六个月公司累计收入为1593.60万美元，相比去年同期的1918.20万美元下降了16.92%。作为一家致力于开发精密基因药物的生物科技公司，Beam Therapeutics的研发投入可能是导致亏损扩大的主要原因之一。这份疲软的财报无疑打击了投资者信心，导致股价在交易时段出现大幅下跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BEAM"],"gpt_icon":0},{"id":"2557395633","title":"Beam Therapeutics Q2 EPS $(1.00) Beats $(1.12) Estimate, Sales $8.47M Miss $13.56M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557395633","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557395633?lang=zh_cn&edition=full","pubTime":"2025-08-05 19:23","pubTimestamp":1754393031,"startTime":"0","endTime":"0","summary":"Beam Therapeutics Q2 EPS $(1.00) Beats $(1.12) Estimate, Sales $8.47M Miss $13.56M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"Beam Therapeutics第二季度EPS$(1.00)超出预期$(1.12)，销售额847万美元，低于预期1,356万美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46853258/beam-therapeutics-q2-eps-1-00-beats-1-12-estimate-sales-8-47m-miss-13-56m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BEAM"],"gpt_icon":0},{"id":"2557934073","title":"Earnings Flash (BEAM) Beam Therapeutics Posts Q2 $1 Loss, vs. FactSet Est of $1.11 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2557934073","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557934073?lang=zh_cn&edition=full","pubTime":"2025-08-05 19:13","pubTimestamp":1754392405,"startTime":"0","endTime":"0","summary":"Earnings Flash (BEAM) Beam Therapeutics Posts Q2 $1 Loss, vs. FactSet Est of $1.11 Loss","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"收益快讯(BEAM)Beam Therapeutics第二季度亏损1美元，而FactSet预计亏损1.11美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BEAM"],"gpt_icon":0},{"id":"2549528354","title":"Beam Therapeutics Inc.盘中异动 早盘股价大涨5.06%报20.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549528354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549528354?lang=zh_cn&edition=full","pubTime":"2025-07-08 21:37","pubTimestamp":1751981852,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时37分，Beam Therapeutics Inc.股票出现波动，股价快速上涨5.06%。截至发稿，该股报20.15美元/股，成交量29.487万股，换手率0.29%，振幅4.30%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213732953ae602&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4556","BEAM","BK4539","BK4139","BK4007","BK4585","BK4611","BK4505","LENZ","BK4535"],"gpt_icon":0},{"id":"1195291286","title":"Cathie Wood继续抛售Palantir，增持Beam Therapeutics和GitLab","url":"https://stock-news.laohu8.com/highlight/detail?id=1195291286","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195291286?lang=zh_cn&edition=full","pubTime":"2025-06-12 14:40","pubTimestamp":1749710400,"startTime":"0","endTime":"0","summary":"周三，Cathie Wood 的 Ark Invest 进行了多项重要交易，其中最引人注目的包括以下几家公司： $Beam Therapeutics, Inc.$ 、 $GitLab, Inc.$ 、 $Palantir Technologies Inc.$ 、 $Roblox Corporation$ 、 $克瑞拓斯安全防卫$ 、Cloudflare、 $CrowdStrike Holdings, Inc.$ 、 $CoreWeave, Inc.$ 和 $AvidXchange Holdings, Inc$ 。关于 $Beam Therapeutics, Inc.$ 的交易：Ark Invest 旗下的 ARK Innovation ETF买入了 349,264 股 Beam Therapeutics。关于 $Palantir Technologies Inc.$ 的交易：与买入 BEAM 和 GTLB 不同，Ark Invest 选择减持 $Palantir Technologies Inc.$ 的股票，减持行为发生在旗下的多个 ETF 中，包括 ARKK、ARK Autonomo","market":"us","thumbnail":"https://static.tigerbbs.com/0fb0479ff67cd3a760cdce353bcb60ed","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/0fb0479ff67cd3a760cdce353bcb60ed"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"31d054bcd0cb132ff65472312c604202","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEAM","GTLB","PLTR"],"gpt_icon":1},{"id":"2535207423","title":"Beam Therapeutics Inc.盘中异动 临近午盘股价大跌5.04%报17.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535207423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535207423?lang=zh_cn&edition=full","pubTime":"2025-05-14 23:40","pubTimestamp":1747237212,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日23时40分，Beam Therapeutics Inc.股票出现异动，股价快速跳水5.04%。截至发稿，该股报17.14美元/股，成交量53.4024万股，换手率0.53%，振幅7.04%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.36%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051423401297599e23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BEAM","BK4535","BK4588","BK4505","BK4139","BK4556","BK4585","LENZ","BK4539","BK4007","BK4611"],"gpt_icon":0},{"id":"2534233619","title":"Beam Therapeutics Inc.2025财年第一财季实现净利润-1.09亿美元，同比减少10.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534233619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534233619?lang=zh_cn&edition=full","pubTime":"2025-05-12 00:00","pubTimestamp":1746979249,"startTime":"0","endTime":"0","summary":"5月12日，Beam Therapeutics Inc.公布财报，公告显示公司2025财年第一财季净利润为-1.09亿美元，同比减少10.47%；其中营业收入为7.47百万美元，同比增加0.81%，每股基本收益为-1.24美元。从资产负债表来看，Beam Therapeutics Inc.总负债3.44亿美元，其中短期债务13.21百万美元，资产负债比为4.27，流动比率为8.79。机构评级：截至2025年5月12日，当前有16家机构对Beam Therapeutics Inc.目标价做出预测，其中目标均价为43.75美元，其中最低目标价为20.00美元，最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512000215a47a493c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BEAM","LENZ"],"gpt_icon":0},{"id":"1157820864","title":"异动解读 | 基因编辑公司Beam Therapeutics盘中大涨8.17%，投资者看好其长期潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1157820864","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157820864?lang=zh_cn&edition=full","pubTime":"2025-05-09 22:01","pubTimestamp":1746799287,"startTime":"0","endTime":"0","summary":"周五交易时段，基因编辑技术公司Beam Therapeutics股价出现显著上涨，盘中大涨8.17%，引发市场广泛关注。尽管近期面临分析师下调目标价的压力，但投资者似乎对该公司的长期发展前景保持乐观态度。Beam Therapeutics是一家专注于开发精准基因药物的生物技术公司，其核心技术是专有的碱基编辑技术。尽管巴克莱近期将Beam Therapeutics的目标价从31美元下调至25美元，但市场反应似乎与这一负面消息相悖。生物技术行业的整体上涨趋势也可能为BEAM股价提供了支撑。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 基因编辑公司Beam Therapeutics盘中大涨8.17%，投资者看好其长期潜力","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BEAM"],"gpt_icon":1},{"id":"2534304480","title":"Beam Therapeutics Inc.盘中异动 早盘快速拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534304480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534304480?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:34","pubTimestamp":1746797671,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时34分，Beam Therapeutics Inc.股票出现异动，股价急速上涨5.16%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。该信息摘要如下：巴克莱：维持Beam Therapeutics评级，由持股观望调整至持股观望评级, 目标价由31.00美元调整至25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921343294f1d5a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","BK4505","BK4585","BK4588","BK4611","BEAM","BK4007","LENZ","BK4539","BK4535"],"gpt_icon":0},{"id":"2533938306","title":"巴克莱：维持Beam Therapeutics(BEAM.US)评级，由持股观望调整至持股观望评级, 目标价由31.00美元调整至25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533938306","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533938306?lang=zh_cn&edition=full","pubTime":"2025-05-07 20:52","pubTimestamp":1746622342,"startTime":"0","endTime":"0","summary":"巴克莱：维持Beam Therapeutics(BEAM.US)评级，由持股观望调整至持股观望评级, 目标价由31.00美元调整至25.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/07205250206786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BEAM","LENZ"],"gpt_icon":0},{"id":"2533966165","title":"Sector Update: Health Care Stocks Fall Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2533966165","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533966165?lang=zh_cn&edition=full","pubTime":"2025-05-07 03:56","pubTimestamp":1746561377,"startTime":"0","endTime":"0","summary":"Health care stocks declined late Tuesday afternoon, with the NYSE Health Care Index falling 2.6% and the Health Care Select Sector SPDR Fund  dropping 2.7%.The iShares Biotechnology ETF  slumped 5.7%.In sector news, the US Food and Drug Administration said Tuesday it plans to expand its use of surprise inspections at foreign facilities that make food, essential medicines, and other medical products for US consumers.In corporate news, NuCana  shares tumbled 66% after it priced a $7 million registered direct offering.Heron Therapeutics  shares jumped past 13% after the firm said it reached a settlement agreement with Viatris'  Mylan Pharmaceuticals to resolve patent litigation over the Cinvanti and Aponvie injectable emulsions. Viatris lost 0.8%.Beam Therapeutics  shares tumbled nearly 20% after it reported a wider Q1 loss compared with a year earlier.Philips  shares fell 5.9% after it reported flat Q1 adjusted earnings per share, while sales declined.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"行业更新：医疗保健股午后下跌","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4611","BK4588","BK4505","BK4581","NCNA","BEAM","BK4585","BK4082","PHG","BK4139","BK4535","XLV","BK4007","LU1839511570.USD","VTRS","BK4556","HRTX","LU2087621335.USD","IBB","BK4583"],"gpt_icon":0},{"id":"2533821663","title":"Sector Update: Health Care Stocks Lower in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2533821663","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533821663?lang=zh_cn&edition=full","pubTime":"2025-05-07 02:05","pubTimestamp":1746554704,"startTime":"0","endTime":"0","summary":"Health care stocks declined Tuesday afternoon, with the NYSE Health Care Index falling 2.1% and the Health Care Select Sector SPDR Fund  dropping 2.8%.The iShares Biotechnology ETF  slumped 6%.In corporate news, Beam Therapeutics  shares tumbled past 17% after it reported a wider Q1 loss compared with a year earlier.Philips  shares fell 5.5% after it reported flat Q1 adjusted earnings per share, while sales declined.Viridian Therapeutics  shares were down 7.4% after it reported a Q1 net loss of $0.87 per diluted share, widening from a loss of $0.59 a year earlier.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"行业更新：医疗保健股下午交易走低","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BEAM","BK4505","BK4535","IBB","BK4585","XLV","BK4611","BK4082","BK4556","BK4139","VRDN","BK4581","PHG"],"gpt_icon":0},{"id":"2533963064","title":"Beam Therapeutics Shares Fall After Q1 Net Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2533963064","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533963064?lang=zh_cn&edition=full","pubTime":"2025-05-06 21:49","pubTimestamp":1746539385,"startTime":"0","endTime":"0","summary":"Beam Therapeutics  fell more than 5% in recent trading Tuesday after reporting a wider Q1 loss from the same period a year earlier.The company reported a Q1 net loss of $1.24 per share, widening from a loss of $1.21 a year earlier.Analysts polled by FactSet expected a loss of $1.18.License and collaboration revenue for the quarter ended March 31 was $7.5 million, up from $7.4 million a year earlier.Analysts surveyed by FactSet expected $14 million.The company said it had cash, cash equivalents and marketable securities of $1.22 billion as of March 31 to finance its expected operating expenses and capital expenditure requirements into 2028.Price: 18.75, Change: -1.07, Percent Change: -5.40","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"Beam Therapeutics第一季度净亏损扩大后股价下跌","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","LENZ","BK4611","BK4588","BK4535","BK4007","BK4139","BEAM","BK4556","BK4585"],"gpt_icon":0},{"id":"2533684171","title":"Earnings Flash (BEAM) Beam Therapeutics Posts Q1 License and Collaboration Revenue $7.5M","url":"https://stock-news.laohu8.com/highlight/detail?id=2533684171","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533684171?lang=zh_cn&edition=full","pubTime":"2025-05-06 19:39","pubTimestamp":1746531581,"startTime":"0","endTime":"0","summary":"Earnings Flash (BEAM) Beam Therapeutics Posts Q1 License and Collaboration Revenue $7.5M","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"财报(BEAM)Beam Therapeutics公布第一季度许可和合作收入750万美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BEAM"],"gpt_icon":0},{"id":"2533203681","title":"Earnings Flash (BEAM) Beam Therapeutics Posts Q1 Loss $1.24, vs. FactSet Est of -$1.18","url":"https://stock-news.laohu8.com/highlight/detail?id=2533203681","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533203681?lang=zh_cn&edition=full","pubTime":"2025-05-06 19:29","pubTimestamp":1746530998,"startTime":"0","endTime":"0","summary":"Earnings Flash (BEAM) Beam Therapeutics Posts Q1 Loss $1.24, vs. FactSet Est of -$1.18","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"收益快讯(BEAM)Beam Therapeutics公布第一季度亏损1.24美元，而FactSet预期为-1.18美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BEAM"],"gpt_icon":0},{"id":"2529899446","title":"Beam Therapeutics Inc.盘中异动 快速拉升5.85%报20.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529899446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529899446?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:30","pubTimestamp":1745415050,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时30分，Beam Therapeutics Inc.股票出现波动，股价急速拉升5.85%。截至发稿，该股报20.25美元/股，成交量3.2606万股，换手率0.03%，振幅0.00%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213051a6c53c18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4556","BEAM","BK4139","BK4007","BK4585","BK4611","BK4505","LENZ","BK4535"],"gpt_icon":0},{"id":"2529669534","title":"Beam Therapeutics Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529669534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529669534?lang=zh_cn&edition=full","pubTime":"2025-04-23 00:02","pubTimestamp":1745337751,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日00时02分，Beam Therapeutics Inc.股票出现波动，股价大幅上涨5.04%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为2.03%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230002329740de7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","BK4505","BK4585","BK4588","BK4611","BEAM","BK4007","LENZ","BK4535"],"gpt_icon":0},{"id":"2529002118","title":"Beam Therapeutics Inc.盘中异动 早盘快速拉升5.06%报17.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529002118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529002118?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:09","pubTimestamp":1745244551,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时09分，Beam Therapeutics Inc.股票出现波动，股价快速拉升5.06%。截至发稿，该股报17.86美元/股，成交量19.0309万股，换手率0.19%，振幅6.61%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421220911aa2c7438&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BEAM","BK4588","BK4007","BK4585","BK4535","LENZ","BK4556","BK4611","BK4505","BK4139"],"gpt_icon":0},{"id":"2527408246","title":"Beam Therapeutics Inc.盘中异动 快速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527408246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527408246?lang=zh_cn&edition=full","pubTime":"2025-04-16 21:53","pubTimestamp":1744811592,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时53分，Beam Therapeutics Inc.股票出现异动，股价大幅下跌5.03%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.12%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041621531294d7885c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LENZ","BK4007","BK4139","BK4535","BK4556","BK4611","BK4585","BEAM","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beamtx.com","stockEarnings":[{"period":"1week","weight":0.1806},{"period":"1month","weight":0.5143},{"period":"3month","weight":0.4511},{"period":"6month","weight":0.0438},{"period":"1year","weight":-0.0661},{"period":"ytd","weight":-0.0194}],"compareEarnings":[{"period":"1week","weight":0.0096},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.1168},{"period":"6month","weight":0.1768},{"period":"1year","weight":0.1624},{"period":"ytd","weight":0.1324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Beam Therapeutics Inc.成立于2017年1月25日，是一家生物技术公司，致力于根据其专有的碱基编辑技术创建一类新型的精密基因药物，其愿景是为患有严重疾病的患者提供终身治疗疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.020436},{"month":2,"riseRate":0.6,"avgChangeRate":0.123426},{"month":3,"riseRate":0,"avgChangeRate":-0.205206},{"month":4,"riseRate":0.5,"avgChangeRate":-0.128126},{"month":5,"riseRate":0.5,"avgChangeRate":0.074807},{"month":6,"riseRate":0.833333,"avgChangeRate":0.150103},{"month":7,"riseRate":0.5,"avgChangeRate":0.084734},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.03415},{"month":9,"riseRate":0.333333,"avgChangeRate":0.013304},{"month":10,"riseRate":0.4,"avgChangeRate":0.021253},{"month":11,"riseRate":0.8,"avgChangeRate":0.196147},{"month":12,"riseRate":0.4,"avgChangeRate":0.072364}],"exchange":"NASDAQ","name":"Beam Therapeutics, Inc.","nameEN":"Beam Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Beam Therapeutics, Inc.(BEAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Beam Therapeutics, Inc.(BEAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Beam Therapeutics, Inc.,BEAM,Beam Therapeutics, Inc.股票,Beam Therapeutics, Inc.股票老虎,Beam Therapeutics, Inc.股票老虎国际,Beam Therapeutics, Inc.行情,Beam Therapeutics, Inc.股票行情,Beam Therapeutics, Inc.股价,Beam Therapeutics, Inc.股市,Beam Therapeutics, Inc.股票价格,Beam Therapeutics, Inc.股票交易,Beam Therapeutics, Inc.股票购买,Beam Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beam Therapeutics, Inc.(BEAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Beam Therapeutics, Inc.(BEAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}